This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Mycoplasma fermentans infection induces human necrotic neuronal cell death via IFITM3-mediated amyloid-β (1–42) deposition
Scientific Reports Open Access 26 April 2023
-
More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins
Retrovirology Open Access 21 November 2017
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bailey CC, Zhong G, Huang IC, Farzan M. IFITM-family proteins: the cell’s first line of antiviral defense. Annu Rev Virol 2014; 1: 261–283.
Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 2011; 7: e1002337.
Yount JS, Karssemeijer RA, Hang HC. S-palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J Biol Chem 2012; 287: 19631–19641.
Desai TM, Marin M, Chin CR, Savidis G, Brass AL, Melikyan GB. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog 2014; 10: e1004048.
Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog 2013; 9: e1003124.
Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009; 139: 1243–1254.
Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, López CB et al. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 2010; 6: 610–614.
Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 2012; 484: 519–523.
Bailey CC, Huang IC, Kam C, Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog 2012; 8: e1002909.
Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci USA 2013; 111: 769–774.
Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is aFssociated with severe influenza in Chinese individuals. Nat Commun 2013; 4: 1418.
Jiang LQ, Tian X, Hu YH, Sun MS, Yan S, Lei CQ et al. IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3. Cell Mol Immunol 2017. In Press.
Porritt RA, Hertzog PJ. Dynamic control of type I IFN signalling by an integrated network of negative regulators. Trends Immunol 2015; 36: 150–160.
Chesarino NM, McMichael TM, Hach JC, Yount JS. Phosphorylation of the antiviral protein interferon-inducible transmembrane protein 3 (IFITM3) dually regulates its endocytosis and ubiquitination. J Biol Chem 2014; 289: 11986–11992.
Acknowledgements
TMM is supported by a Gilliam Graduate Fellowship from the Howard Hughes Medical Institute. JSY is supported by NIH Grant AI130110.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
McMichael, T.M., Chemudupati, M. & Yount, J.S. A balancing act between IFITM3 and IRF3. Cell Mol Immunol 15, 873–874 (2018). https://doi.org/10.1038/cmi.2017.18
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2017.18